Header Logo

Connection

Joy Sclamberg to Germ-Line Mutation

Back to Details
This is a "connection" page, showing publications Joy Sclamberg has written about Germ-Line Mutation.
Joy Sclamberg
Connection Strength
0.047
Germ-Line Mutation
  1. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation. Oncologist. 2021 10; 26(10):811-817.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.